Recommanded Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Antibodies | Mechanisms of Transplacental IgG Antibody Transfer from Mother to Fetus, Pregnancy-Related Disorders, and Emerging Experimental Models
2026-02-22
【Frontier Express】Signal Transduction and Targeted Therapy | Consensus Molecular Subtypes and Image-Based Classification System for Esophageal Squamous Cell Carcinoma
2026-02-22
【Frontier Express】Nature Reviews. Drug Discovery | Novel Strategies for Treating Genetic Disorders by Modulating Gene Expression
2026-02-22
【Frontier Express】Antibodies | Antibody Avidity Profiles for Differentiating Acute and Chronic Anisakis simplex—Related Allergic Diseases
2026-02-22
【Frontier Express】Nature Reviews. Cancer | Defining a 'Cells to Society' Research Framework for Appendiceal Tumours
2026-02-21
【Frontier Express】Nature Reviews Molecular Cell Biology | Histone Lysine L-Lactylation: Biochemical Mechanisms and Regulatory Networks
2026-02-21
【Frontier Express】Signal Transduction and Targeted Therapy | RNF213 Regulates B Cell Receptor Signaling, Metabolism, and B Lymphocyte Development
2026-02-20






